Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.38 |
| ▸ | ADH1A | P07327 | 5/20 | 0.36 |
| ▸ | ADH1C | P00326 | 4/20 | 0.36 |
| ▸ | ADH1B | P00325 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19148860 | 0.98 | SHBG (0.34) | SHBGADH1AADH1CADH1BMEN1 | |
| SCHEMBL896726 | 0.79 | SHBG (0.42) | SHBGADH1AADH1CADH1BMEN1 | |
| SCHEMBL2481387 | 0.77 | SHBG (0.41) | SHBGADH1AADH1CADH1BMEN1 | |
| SCHEMBL14317675 | 0.77 | ADH1A (0.46) | ADH1AADH1CADH1BMEN1ALDH1A1 | |
| SCHEMBL17053458 | 0.76 | SHBG (0.39) | SHBGADH1AADH1CADH1BMEN1 | |
| SCHEMBL17056102 | 0.76 | SHBG (0.39) | SHBGADH1AADH1CADH1BMEN1 | |
| SCHEMBL19149766 | 0.74 | ADH1A (0.43) | ADH1AADH1CADH1B | |
| SCHEMBL19148100 | 0.74 | SHBG (0.34) | SHBGADH1AADH1CADH1BMEN1 | |
| SCHEMBL17053457 | 0.73 | SHBG (0.36) | SHBGADH1AADH1CADH1BMEN1 | |
| SCHEMBL19150105 | 0.73 | ALDH1A1 (0.38) | SHBGADH1AADH1CADH1BMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11735413-B2 | Precursors and flowable CVD methods for making low-k films to fill surface features | VERSUM MATERIALS US, LLC (US) | 2023-08-22 | — | — | US | disclosed |
| US-10294250-B2 | Organoaminosilanes and methods for making same | VERSUM MATERIALS US, LLC (US) | 2019-05-21 | — | — | US | disclosed |
| US-20180122631-A1 | Precursors and Flowable CVD Methods for Making Low-K Films to Fill Surface Features Features | VERSUM MATERIALS US, LLC | 2018-05-03 | — | — | US | disclosed |
| US-9758534-B2 | Organoaminosilanes and methods for making same | VERSUM MATERIALS US, LLC (US) | 2017-09-12 | — | — | US | disclosed |
| US-20170204120-A1 | Organoaminosilanes and Methods for Making Same | VERSUM MATERIALS US, LLC (US) | 2017-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170204120-A1 | Organoaminosilanes and Methods for Making Same | DDAH1, IDUA, DDT | SHBG 694/4885ADH1A 160/4885ADH1C 498/4885 |
| US-10294250-B2 | Organoaminosilanes and methods for making same | DDAH1, IDUA, DDT | SHBG 694/4885ADH1A 160/4885ADH1C 498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.